Table 1.
Investigations done during the patient hospitalization.
| Component | Upon presentation | In MICU | Reference range |
|---|---|---|---|
| WBC | 14.7 × 1000/mm3 | 8.4 × 1000/mm3 | 4 × 1000–10 × 1000/mm3 |
| Hemoglobin | 7.4 | 2.5 | 13–17 g/dL |
| Platelets | 480 × 1000/mm3 | 113 × 1000/mm3, then 47 × 1000/mm3 | 150 × 1000–400 × 1000/mm3 |
| Creatinine | 118 | 222 | 62–124 umol/L |
| BUN | 8.3 | 11.5 | 1.7–8.3 mmol/L |
| Potassium | 4.6 | 5.2 | 3.6–5.1 mmol/L |
| Sodium | 134 | 134 | 135–145 mmol/L |
| Chloride | 98 | 98 | 96–110 mmol/L |
| Bicarbonate | 22 | 9 | 24–30 mmol/L |
| AST | 53 | 4425 | 12–39 u/L |
| ALT | 16 | 670 | 0–40 u/L |
| ALP | 472 | 1396 | 40–129 u/L |
| GGT | 155 | 11–50 U/L | |
| Bilirubin | 115 then 330 | 722 | 3.5–24 umol/L |
| Direct bilirubin | 306 | Up to 7 umol/L | |
| INR | 1.1 | 1.4 then 2.3 | |
| APTT | 28 | 31 then 49.20 | 26–38.5 seconds |
| β-HCG | 1131379 | 0–5 IU/L | |
| LDH | 2331 | 240–480 U/L | |
| AFP | 1.4 | 0–5 IU/mL | |
| CA19-9 | 9 | 0–37 U/mL | |
| CEA | 1.2 | 0–3 Ug/L | |
| FT4 | 49.4 | Up to 20 pmol/L | |
| TSH | 0.01 | 0.45–4.5 μ/L | |
| Lactic acid | 5, then 14.41 | 0.5–2.2 mmol/L |
WBC: white blood cells, BUN: blood urea nitrogen, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phophatase, GGT: gamma glutamyl transpeptidase, INR: international normalized ratio, APTT: activated partial thromboplastin time, β-HCG: β-human chorionic gonadotropin, LDH: lactate dehydrogenase, AFP: alpha-fetoprotein, CA19-9: carbohydrate antigen 19-9, CEA: carcinoembryonic antigen, FT4: free thyroxine, and TSH: thyroid stimulating hormone.